Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för scullcapflavone II. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2023-03-01

Neobaicalein, a flavonoid from the <i>Scutellaria litwinowii</i> Bornm. & Sint. ex Bornm. induced apoptosis in human leukemic cell lines.

Emami SA, Ramazani E, Mousavi SH, Vahdati-Mashhadian N, Asili J, Parsaee H, Tayarani-Najaran Z.

Iran J Basic Med Sci · research-article; journal article · DOI 10.22038/ijbms.2023.66240.14616

Bibliografisk träff 2023-02-07

Corrigendum: Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types.

Lee Y, Oh JH, Li N, Jang HJ, Ahn KS, Oh SR, Lee DH, Chung JH.

Front Immunol · published erratum; correction · DOI 10.3389/fimmu.2023.1150830

Bibliografisk träff 2023-01-25

Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice.

Dong YP, Chen SZ, He HS, Sun ZR, Jiang LX, Gu YQ, Zhang Y, Feng F, Chen C, Fan ZC, Chen XF, Wen W, Wang HY.

Acta Pharmacol Sin · research-article; journal article · DOI 10.1038/s41401-023-01052-3

Bibliografisk träff 2023-01-01

Neobaicalein prevents isoflurane anesthesia-induced cognitive impairment in neonatal mice via regulating CREB1.

Wu N, Liu H, Lv X, Sun Y, Jiang H.

Clinics (Sao Paulo) · research-article; journal article · DOI 10.1016/j.clinsp.2023.100201

Bibliografisk träff 2022-12-20

Topical Skullcapflavone II attenuates atopic dermatitis in a mouse model by directly inhibiting associated cytokines in different cell types.

Lee Y, Oh JH, Li N, Jang HJ, Ahn KS, Oh SR, Lee DH, Chung JH.

Front Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3389/fimmu.2022.1064515

Bibliografisk träff 2022-04-07

Insights into the inhibitory mechanism of skullcapflavone II against α-synuclein aggregation and its mediated cytotoxicity.

Parsafar S, Aliakbari F, Seyedfatemi SS, Najarzadeh Z, Hourfar H, Bardania H, Farhadpour M, Mohammadi M, Morshedi D.

Int J Biol Macromol · journal article · DOI 10.1016/j.ijbiomac.2022.03.092

Bibliografisk träff 2019-06-04

Skullcapflavone II Inhibits Degradation of Type I Collagen by Suppressing MMP-1 Transcription in Human Skin Fibroblasts.

Lee YH, Seo EK, Lee ST.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms20112734

Bibliografisk träff 2017-09-05

Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release.

Bui TT, Piao CH, Song CH, Chai OH.

Int Immunopharmacol · journal article · DOI 10.1016/j.intimp.2017.08.029

Bibliografisk träff 2014-12-16

Growth inhibition and apoptosis induction by Scutellaria pinnatifida A. Ham. on HL-60 and K562 leukemic cell lines.

Boozari M, Mohammadi A, Asili J, Emami SA, Tayarani-Najaran Z.

Environ Toxicol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.etap.2014.12.002

Bibliografisk träff 2012-02-04

Skullcapflavone II inhibits ovalbumin-induced airway inflammation in a mouse model of asthma.

Jang HY, Ahn KS, Park MJ, Kwon OK, Lee HK, Oh SR.

Int Immunopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.intimp.2012.01.010